ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

PHS Revises Lab Animal Policies

May 10, 1985

Carbone Heads Chairmen’s Group

June 30, 1978

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006